Current State-of-the-art In-house and Cloud-Based Applications of Virtual Polymorph Screening of Pharmaceutical Compounds: A Challenging Case of AZD1305-Reference-Cited by-同舟云学术

Current State-of-the-art In-house and Cloud-Based Applications of Virtual Polymorph Screening of Pharmaceutical Compounds: A Challenging Case of AZD1305

Published:2021-03-01 Issue:4 Volume:21 Page:1972-1983
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Sun GuangXu¹²,Liu Xuetao¹²,Abramov Yuriy A.³⁴^ORCID,Nilsson Lill Sten O.⁵,Chang Chao²,Burger Virginia³,Broo Anders⁶

Affiliation:

1. Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogeomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China

2. XtalPi Inc., Shenzhen Jingtai Technology Co., Limited, Floor 4, No. 9, Hualian Industrial Zone, Dalang Street, Longhua District, Shenzhen 518100, China

3. XtalPi Inc., 245 Main Street, Cambridge, Massachusetts 02142, United States

4. Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

5. Early Product Development and Manufacturing, Pharmaceutical Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, Mölndal SE-431 83, Sweden

6. Data Science and Modelling, Pharmaceutical Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, Mölndal SE-431 83, Sweden

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.0c01266

Reference85 articles.

1. Impact of solid state properties on developability assessment of drug candidates